Invesco’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $797K | Buy |
|
|||||
|
2025
Q2 | $381K | Sell |
|
|||||
|
2025
Q1 | $2.41M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $17M | Buy |
|
|||||
|
2024
Q2 | $153K | Buy |
|
|||||
|
2024
Q1 | $127K | Buy |
|
|||||
|
2023
Q4 | $122K | Sell |
|
|||||
|
2023
Q3 | $101K | Buy |
|
|||||
|
2023
Q2 | $113K | Buy |
|
|||||
|
2023
Q1 | $110K | Sell |
|
|||||
|
2022
Q4 | $254K | Sell |
|
|||||
|
2022
Q3 | $6.1M | Buy |
|
|||||
|
2022
Q2 | $5.83M | Sell |
|
|||||
|
2022
Q1 | $15.4M | Sell |
|
|||||
|
2021
Q4 | $13.7M | Sell |
|
|||||
|
2021
Q3 | $18.8M | Buy |
|
|||||
|
2021
Q2 | $22.4M | Buy |
|
|||||
|
2021
Q1 | $17.6M | Buy |
|
|||||
|
2020
Q4 | $17.9M | Buy |
|
|||||
|
2020
Q3 | $12M | Buy |
|
|||||
|
2020
Q2 | $9.17M | Buy |
|
|||||
|
2020
Q1 | $7.82M | Buy |
|
|||||
|
2019
Q4 | $10.7M | Hold |
|
|||||
|
2019
Q3 | $9.35M | Hold |
|
|||||
|
2019
Q2 | $13.1M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $41K | Buy |
|
|||||
|
2017
Q4 | $41K | Sell |
|
|||||
|
2017
Q3 | $29K | Buy |
|
|||||
|
2017
Q2 | $30K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $81K | Sell |
|
|||||
|
2016
Q1 | $114K | Sell |
|
|||||
|
2015
Q4 | $282K | Buy |
|
|||||
|
2015
Q3 | $225K | Buy |
|
|||||
|
2015
Q2 | $288K | Buy |
|
|||||
|
2015
Q1 | $192K | Sell |
|
|||||
|
2014
Q4 | $143K | Buy |
|
|||||
|
2014
Q3 | $116K | Buy |
|
|||||
|
2014
Q2 | $206K | Sell |
|
|||||
|
2014
Q1 | $222K | Buy |
|
|||||
|
2013
Q4 | $55K | Buy |
|
|||||
|
2013
Q3 | $64K | Buy |
|
|||||
|
2013
Q2 | $54K | Buy |
|